Abstract
Heat shock proteins (HSPs) or chaperonins, as they were previously named, are a group of evolutionarily conserved proteins that show high sequence homology between different species, from bacteria to humans (Morimoto. Science. 1993;259:1409–10). They are involved in maintaining various cellular proteins in their correctly folded functional forms (Patterson and Cyr. Circulation. 2002;106:2741–6). These proteins have several functions such as cytoprotection and intracellular assembly, stabilization, folding, and translocation of oligomeric proteins (Hightower. Cell 1991;66:191–7). In particular, heat shock protein 60 (HSP60) is a mitochondrial protein constitutively expressed in the majority of cells, and its expression is upregulated by a variety of stressors. In the setting of cardiovascular disease, higher titers of antibody to HSPs have been reported in atherosclerosis, which may contribute to immunoactivation in this process and other similar conditions. In heart failure, HSP60 is released from cardiomyocytes; it has been demonstrated in several studies that increased serum HSP60 is related to the severity of the disease. In fact, high levels of sHSP60 correlate with worse prognosis and higher mortality rate in patients with acute heart failure (AHF) (Bonanad et al. Congest Heart Fail. 2013;19:6–10).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AHF:
-
Acute Heart Failure
- CHD:
-
Coronary Heart Disease
- CHF:
-
Chronic Heart Failure
- ELISA:
-
Enzyme-Linked Immunosorbent Assay
- HF:
-
Heart Failure
- HPSs:
-
Heat Shock Proteins
- HR:
-
Heart Rate
- IQR:
-
Interquartile Range
- LVEF:
-
Left Ventricular Ejection Fraction
- sHSP60:
-
Serum Heat Shock Protein 60
- T:
-
Tertile
- TLR4:
-
Toll-like Receptor 4
References
Acunzo J, Katsogiannou M, Rocchi P. Small heat shock proteins HSP27 (HspB1), αB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death. Int J Biochem Cell Biol. 2012;44:1622–31. doi:10.1016/j.biocel.2012.04.002.
Amberger A, Maczek C, Jürgens G, Michaelis D, Schett G, Trieb K, et al. Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. Cell Stress Chaperones. 1997;2:94–103.
Antonova G, Lichtenbeld H, Xia T, Chatterjee A, Dimitropoulou C, Catravas JD. Functional significance of hsp90 complexes with NOS and sGC in endothelial cells. Clin Hemorheol Microcirc. 2007;37:19–35.
Benjamin IJ, McMillan DR. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ Res. 1998;83:117–32.
Birnie DH, Hood S, Holmes E, Hillis WS. Anti-heat shock protein 65 titres in acute myocardial infarction. Lancet. 1994;344:1443.
Birnie D, McKay IC, Veitch J, Whaley K, Hood S, Hillis WS, et al. Antimycobacterial hsp65 and rheumatoid factor titres in a population of normal twins: evidence of genetic control of rheumatoid factor. Clin Exp Immunol. 1995;101:393–7.
Birnie DH, Holme ER, McKay IC, Hood S, McColl KE, Hillis WS. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J. 1998;19:387–94.
Birnie DH, Vickers LE, Hillis WS, et al. Increased titres of anti-human heat shock protein 60 predict an adverse one year prognosis in patients with acute cardiac chest pain. Heart. 2005;91:1148–53.
Bonanad C, Núñez J, Sanchis J, Bodi V, Chaustre F, Chillet M, et al. Serum heat shock protein 60 in acute heart failure: a new biomarker? Congest Heart Fail. 2013;19:6–10. doi:10.1111/j.1751-7133.2012.00299.x.
Davies KJ. Degradation of oxidized proteins by the 20S proteasome. Biochimie. 2001;83:301–10.
George J, Afek A, Gilburd B, et al. Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. J Am Coll Cardiol. 2001;38:900–5.
Ghayour-Mobarhan M, New SA, Lamb DJ, Starkey BJ, Livingstone C, Wang T, et al. Dietary antioxidants and fat are associated with plasma antibody titers to heat shock proteins 60, 65, and 70 in subjects with dyslipidemia. Am J Clin Nutr. 2005;81:998–1004.
Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature. 2003;426:895–9.
Gupta S, Knowlton AA. Cytosolic heat shock protein 60, hypoxia, and apoptosis. Circulation. 2002;106:2727–33.
Gupta S, Knowlton AA. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circ Physiol. 2007;292:H3052–6.
Hightower LE. Heat shock, stress proteins, chaperones and proteotoxicity. Cell. 1991;66:191–7.
Hooper PL. Insulin signaling, GSK-3, heat shock proteins and the natural history of type 2 diabetes mellitus: a hypothesis. Metab Syndr Relat Disord. 2007;5(3):220–30. doi:10.1089/met.2007.0005.
Kaufmann SHE. Heat shock proteins and the immune response. Immunol Today. 1990;11:129–36.
Kirchhoff SR, Gupta S, Knowlton AA. Cytosolic heat shock protein 60, apoptosis, and myocardial injury. Circulation. 2002;105:2899–904.
Knoflach M, Kiechl S, Kind M, Said M, Sief R, Gisinger M, et al. Cardiovascular risk factors and atherosclerosis in young males: ARMY study (Atherosclerosis Risk-Factors in Male Youngsters). Circulation. 2003;108:1064–9.
Knoflach M, Bernhard D, Wick G. Anti-HSP60 immunity is already associated with atherosclerosis early in life. Ann N Y Acad Sci. 2005;1051:323–31.
Knowlton AA, Kapadia S, Torre-Amione G, Durand JB, Bies R, Young J, et al. Differential expression of heat shock proteins in normal and failing human hearts. J Mol Cell Cardiol. 1998;30:811–8.
Kreutmayer SB, Messner B, Knoflach M, Henderson B, Niederegger H, Böck G, et al. Dynamics of heat shock protein 60 in endothelial cells exposed to cigarette smoke extract. J Mol Cell Cardiol. 2011;51:777–80.
Li Z, Song Y, Xing R, Yu H, Zhang Y, Li Z, et al. Heat shock protein 70 acts as a potential biomarker for early diagnosis of heart failure. PLoS ONE. 2013;8:e67964. doi:10.1371/journal.pone.0067964.
Lin KM, Lin B, Lian IY, Mestril R, Scheffer IE, Dillmann WH. Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation. 2001;103:1787–92.
Lin L, Kim SC, Wang Y, Gupta S, Davis B, Simon SI, et al. HSP60 in heart failure: abnormal distribution and role in cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol. 2007;293:H2238–47.
Marunouchi T, Abe Y, Murata M, Inomata S, Sanbe A, Takagi N, et al. Changes in small heat shock proteins HSPB1, HSPB5 and HSPB8 in mitochondria of the failing heart following myocardial infarction in rats. Biol Pharm Bull. 2013;36:529–39.
Mayr M, Metzler B, Kiechl S, Willeit J, Schett G, Xu Q, et al. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumonia. Immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation. 1999;99:1560–6.
Millonig G, Schwentner C, Mueller P, Mayerl C, Wick G. The vascular-associated lymphoid tissue: a new site of local immunity. Curr Opin Lipidol. 2001;12:547–53.
Millonig G, Malcom GT, Wick G. Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study. Atherosclerosis. 2002;160:441–8.
Morimoto RI. Cells in stress: transcriptional activation of heat shock genes. Science. 1993;259:1409–10.
Niizeki T, Takeishi Y, Watanabe T, Nitobe J, Miyashita T, Miyamoto T, et al. Relation of serum heat shock protein 60 level to severity and prognosis in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2008;102:606–10.
Patterson C, Cyr D. Welcome to the machine: a cardiologist’s introduction to protein folding and degradation. Circulation. 2002;106:2741–6.
Paulsson G, Zhou X, Törnquist E, Hansson GK. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2000;20:10–7.
Pockley AG. Heat shock proteins, inflammation, and cardiovascular disease. Circulation. 2002;105:1012–7.
Pockley AG, Frostegård J. Heat shock proteins in cardiovascular disease and the prognostic value of heat shock protein related measurements. Heart. 2005;91:1124–6.
Pockley AG, Bulmer J, Hanks BM, Wright BH. Identification of human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies in the peripheral circulation of normal individuals. Cell Stress Chaperones. 1999;4:29–35.
Pockley AG, Wu R, Lemne C, Kiessling R, de Faire U, Frostegård J. Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension. 2000;36:303–7.
Powell SR. The ubiquitin-proteasome system in cardiac physiology and pathology. Am J Physiol Heart Circ Physiol. 2006;291:H1–19.
Rossmann A, Henderson B, Heidecker B, Seiler R, Fraedrich G, Singh M, et al. T-cells from advanced atherosclerotic lesions recognize hHSP60 and have a restricted T-cell receptor repertoire. Exp Gerontol. 2008;43:229–37. doi:10.1016/j.exger.2007.11.009.
Saban KL, Hoppensteadt D, Bryant FB, Devon HA. Social determinants and heat shock protein-70 among african american and non-hispanic white women with atherosclerosis: a pilot study. Biol Res Nurs. 2013;16(3):258–265.
Sanbe A, Marunouchi T, Abe T, Tezuka Y, Okada M, Aoki S, et al. Phenotype of cardiomyopathy in cardiac-specific heat shock protein B8 K141N transgenic mouse. J Biol Chem. 2013;288:8910–21. doi:10.1074/jbc.M112.368324.
Schett G, Xu Q, Amberger A, Van der Zee R, Recheis H, Willeit J, et al. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest. 1995;96(6):2569–77.
Seibert TA, Hibbert B, Chen YX, Rayner K, Simard T, Hu T, et al. Serum heat shock protein 27 levels represent a potential therapeutic target for atherosclerosis: observations from a human cohort and treatment of female mice. J Am Coll Cardiol. 2013. doi:10.1016/j.jacc.2013.05.041.
Shamaei-Tousi A, Stephens JW, Bin R, Cooper JA, Steptoe A, Coates AR, et al. Association between plasma levels of heat shock protein 60 and cardiovascular disease in patients with diabetes mellitus. Eur Heart J. 2006;27:1565–70.
Shin YO, Bae JS, Lee JB, Kim JK, Kim YJ, Kim C, et al. Effect of cardiac rehabilitation and statin treatment on anti-HSP antibody titers in patients with coronary artery disease after percutaneous coronary intervention. Int Heart J. 2006;47:671–82.
Wick G, Perschinka H, Millonig G. Atherosclerosis as an autoimmune disease: an update. Trends Immunol. 2001;22:665–9.
Wick G, Knoflach M, Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol. 2004;22:361–403.
Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler Thromb Vasc Biol. 2002;22:1547–59.
Xu Q, Wick G. The role of heat shock proteins in protection and pathophysiology of the arterial wall. Mol Med Today. 1996;2:372–9.
Xu Q, Kleindienst R, Waitz W, Dietrich H, Wick G. Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J Clin Invest. 1993a;91:2693–702.
Xu Q, Willeit J, Marosi M, Kleindienst R, Oberhollenzer F, Kiechl S, et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet. 1993b;341:255–9.
Xu Q, Kiechl S, Mayr M, Metzler B, Egger G, Oberhollenzer F, et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation. 1999;100:1169–74.
Xu Q, Schett G, Perschinka H, Mayr M, Egger G, Oberhollenzer F, et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation. 2000;102:14–20.
Young RA. Stress proteins and immunology. Ann Rev Immunol. 1990;8:401–20.
Zhang X, He M, Cheng L, Chen Y, Zhou L, Zeng H, et al. Elevated heat shock protein 60 levels are associated with higher risk of coronary heart disease in Chinese. Circulation. 2008;118:2687–93.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Bonanad, C., García-Blas, S., Racugno, P., Ventura, S., Chaustre, F., Núñez, J. (2015). Serum Heat Shock Proteins as Novel Biomarker for Heart Failure and Cardiovascular Diseases. In: Preedy, V., Patel, V. (eds) General Methods in Biomarker Research and their Applications. Biomarkers in Disease: Methods, Discoveries and Applications. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7696-8_13
Download citation
DOI: https://doi.org/10.1007/978-94-007-7696-8_13
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-7695-1
Online ISBN: 978-94-007-7696-8
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences